Metraipolis › archive › dc_13bcd7855868

First-Line Lorlatinib in Striatin-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma: A Case Report and Literature Review — Europe PMC PMID:42698585

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42698585
DOI
10.1002/rcr2.70750
License (as archived)
solo-consultazione
Archived
2026-10-16T05:18:53.833Z
SHA-256 of the archived text
0189edcdd4f591d0ec56f9b1906f3fcd7e20093b3f982ee991bf79c0b246a412
Stable URL of this page
https://metraipolis.com/documento/dc_13bcd7855868

How to cite

First-Line Lorlatinib in Striatin-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma: A Case Report and Literature Review — Europe PMC PMID:42698585 — Europe PMC (en), https://europepmc.org/article/MED/42698585 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13bcd7855868 (Metraipolis archive dc_13bcd7855868, sha256 0189edcdd4f591d0ec56f9b1906f3fcd7e20093b3f982ee991bf79c0b246a412)
BibTeX
@misc{dc13bcd7855868,
  title = {First-Line Lorlatinib in Striatin-Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma: A Case Report and Literature Review — Europe PMC PMID:42698585},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42698585},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13bcd7855868; sha256 0189edcdd4f591d0ec56f9b1906f3fcd7e20093b3f982ee991bf79c0b246a412},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42698585. Agents can read the archived copy with the MCP tool read_document.